Comparison of ultralongacting insulin, glarugine and degludec in type 2 diabetes under basal-bolus insulin treatment
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000010518
- Lead Sponsor
- aga Municipal Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who falls under any of the following conditions shall be excluded: (1)diabetic coma (2)severe renal dysfunction (eGFR less than 30) (3)unstable pre or proliferative diabetic retinopathy (4)severe infection (5)administered steroid drugs (6)pregnant or planned pregnant in the near future (7)ineligible for some other medical reasons judged by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method